Categories Earnings, LATEST, Technology

Key factors to watch when Facebook (FB) reports Q4 results

Facebook Inc. (NASDAQ: FB) is scheduled to report fourth quarter 2019 earnings results on Wednesday, January 29, after the market closes. Analysts estimate earnings to increase to $2.53 per share from $2.38 per share reported a year earlier. Revenue is projected to grow over 23% to $20.89 billion.

Facebook is a leader in the field of digital advertising and this strength is expected to continue in the fourth quarter as well. Last quarter, advertising revenues increased 28% to $17.3 billion.

Facebook Q3 2019 earnings results

Facebook has been diversifying its services and has been investing in areas like video streaming. Investors will be interested in the company’s updates in this area as well as on topics such as its cryptocurrency Libra and political advertising.

As we have witnessed over the past quarters, Facebook continues to see growth in users despite the privacy concerns and negativity it has faced. User growth has been stronger in regions outside the US and Europe. Last quarter, daily active users increased 9% while monthly active users rose 8%.

The social media giant still faces scrutiny on the way it handles its user data and the company continues to invest in improving its privacy features. This has, however, not affected the popularity of the platform significantly.  

In the third quarter of 2019, Facebook beat revenue and earnings estimates. Revenues increased 29% year-over-year to $17.65 billion and EPS rose 20% to $2.12.

Shares of Facebook have gained 45% over the past one year and 15% over the past three months. The stock has a majority rating of Buy and the average price target is $245.74.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top